Marlborough medical device manufacturer Lifeward has named Bob Marshall as its new board chair, as current board chair Joseph Turk is leaving the role as he takes on a larger role at a Waltham-based renal care firm.
Marshall is CFO and treasurer at Lantheus Holdings, a publicly-traded pharmaceutical company based in Billerica specializing in radioactive drugs used to treat conditions like cancer. He’ll take the helm of Lifeward’s board on Jan 1., with Turk leaving as he takes on the role of CEO of care establishment at Fresenius Medical Care.
“Bob has been a valuable member of our board and chair of our audit committee since joining in 2024. His financial leadership, healthcare public company expertise, and strategic perspective will be instrumental as we continue to execute on our strategic growth plans and deliver improved care and outcomes for patients,” Mark Grant, CEO of Lifeward, said in a Friday press release announcing the appointment.
Prior to his time at Lantheus Holdings, Marshall served in various roles in a 16-year stint at Zimmer Biomet Holdings, a publicly-traded medical device company based in Indiana.
Marshall graduated from the University of Notre Dame with a bachelor’s degree in finance and from Indiana University South Bend with an MBA in international finance and management, according to his LinkedIn profile.
Turk first joined Lifeward’s board in 2022. He has been at Fresenius Medical Care since 2019 in various executive vice president roles.
Lifeward is a manufacturer of mobility-related medical devices, including the ReWalk personal exoskeleton, a device which helps those with paralysis walk. Earlier in December, Lifeward announced it is partnering with a Singapore-based firm to expand access to ReWalk to three new markets.
Eric Casey is the managing editor at Worcester Business Journal, who primarily covers the manufacturing and real estate industries.
